☆ 4.6 Article

Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer

HEPATOLOGY INTERNATIONAL (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation

Peng-Xiang Wang et al.

Summary: This study investigated the value of circulating tumor cells (CTCs) as predictors of tumor recurrence following liver transplantation (LTx) in hepatocellular carcinoma (HCC) patients. Results showed that post-operative CTC count >= 1 per 5 mL blood could be a potential biomarker for predicting tumor recurrence, especially in patients with no detectable CTCs before LTx and negative tumor serological markers. Moreover, post-operative serial CTC detection may be useful in post-surgical surveillance for HCC recurrence.

LIVER INTERNATIONAL (2021)

添加到收藏夹

Review Medicine, General & Internal

Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles

Eliza W. Beal et al.

Summary: Intrahepatic cholangiocarcinoma is a rare and aggressive cancer of the biliary tract, with current treatment strategies focusing on surgical resection and emerging adjunctive therapies. Despite advancements in surgical techniques and preoperative evaluation, more effective systemic therapies are still needed to reduce recurrence rates and improve survival outcomes.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Review Oncology

Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact

Natasha Honore et al.

Summary: Liquid biopsy is rapidly evolving as a tool for detecting minimal residual disease in cancer patients, but it still faces technical challenges and limitations that need to be addressed for its clinical applicability.

CANCERS (2021)

添加到收藏夹

Article Oncology

Measurement of Circulating Tumor Cells to Track Hepatocellular Carcinoma Progression After Liver Transplantation-Case Report

Yuan Deng et al.

Summary: This study reported a case where circulating tumor cell (CTC) counts successfully predicted the progression of metastatic colon polyps after interventional therapy for hepatocellular carcinoma (HCC), suggesting that CTC counts can be used to monitor disease progression during HCC metastasis.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives

Yan Peng et al.

Summary: ctDNA, as a non-invasive biomarker, has promising clinical applications for individualized cancer diagnosis and therapy in solid tumors. MRD detection aids in assessing treatment response, patient prognosis, and risk of recurrence.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma

Huang Ao et al.

Summary: Immunotherapy, particularly immune checkpoint inhibitors, has made significant progress in the management of hepatocellular carcinoma (HCC), but the challenge of identifying the optimal responders to ICIs treatment and monitoring treatment effects in a timely manner remains. Liquid biopsy may offer a promising approach to address tumor heterogeneity, identify patients who respond to immunotherapy, monitor treatment effects, and uncover resistance mechanisms.

BIOMARKER RESEARCH (2021)

添加到收藏夹

Article Oncology

Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation

Victor Amado et al.

Summary: Liver transplantation and surgical resection are potential curative options for patients with liver cirrhosis and hepatocellular carcinoma, but tumor recurrence remains a frequent issue. This study aimed to assess the role of circulating tumor cells in HCC patients undergoing surgery and their association with other markers of poor prognosis. Results suggest that incomplete clearance of circulating tumor cells post-surgery may serve as a surrogate marker of HCC aggressiveness.

CANCERS (2021)

添加到收藏夹

Article Oncology

Plasma MicroRNA Panel Predicts Early Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver Transplantation

Ao Huang et al.

Summary: The study demonstrated the significance of plasma microRNA panel for predicting and monitoring early tumor recurrence in hepatocellular carcinoma patients following liver transplantation. The positive status of microRNA panel was associated with a higher recurrence rate, and it changed from negative to positive earlier than AFP and DCP upon recurrence.

JOURNAL OF CANCER (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Role of Molecular Biomarkers in Liver Transplantation for Hepatocellular Carcinoma

Johann von Felden et al.

LIVER TRANSPLANTATION (2020)

添加到收藏夹

Article Oncology

Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma

Jian Wang et al.

ANNALS OF TRANSLATIONAL MEDICINE (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors

Jiaping Li et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Liquid biopsy in the clinical management of hepatocellular carcinoma

Johann von Felden et al.

GUT (2020)

添加到收藏夹

Article Oncology

Analysis of preoperative circulating tumor cells for recurrence in patients with hepatocellular carcinoma after liver transplantation

Zhitao Chen et al.

ANNALS OF TRANSLATIONAL MEDICINE (2020)

添加到收藏夹

Article Oncology

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

Jian Zhou et al.

LIVER CANCER (2020)

添加到收藏夹

Review Oncology

Do We Need to Be Limited by Matching Milan Criteria for Survival in Living Donor Liver Transplantation?

Sami Akbulut et al.

JOURNAL OF GASTROINTESTINAL CANCER (2020)

添加到收藏夹

Review Oncology

Management of Recurrent HCC After Liver Transplantation

Baris Sarici et al.

JOURNAL OF GASTROINTESTINAL CANCER (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience

Michelle R. Ju et al.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

A global view of hepatocellular carcinoma: trends, risk, prevention and management

Ju Dong Yang et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

添加到收藏夹

Review Oncology

How liquid biopsies can change clinical practice in oncology

G. Siravegna et al.

ANNALS OF ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies

Justin I. Odegaard et al.

CLINICAL CANCER RESEARCH (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma

Ao Huang et al.

JOURNAL OF HEPATOLOGY (2017)

添加到收藏夹

Review Gastroenterology & Hepatology

Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches

Gonzalo Sapisochin et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

添加到收藏夹

Article Surgery

Recurrence After Liver Transplantation for Hepatocellular Carcinoma A New MORAL to the Story

Karim J. Halazun et al.

ANNALS OF SURGERY (2017)

添加到收藏夹

Article Oncology

Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity

Ao Huang et al.

JOURNAL OF CANCER (2016)

添加到收藏夹

Review Gastroenterology & Hepatology

Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis

Yu Zhang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing

Daniel C. Koboldt et al.

GENOME RESEARCH (2012)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.